SOC Neurologia

  • Reclutamento aperto

ADVANCE CIDP-1 - A Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase (HYQVIA/HyQvia) and Immune Globulin Infusion (Human) 10% (GAMMAGARD LIQUID/KIOVIG) for the Treatment of Chronic Inflammatory Demyelinating Polyraduculoneuropathy (CIDP)

  • Tipo studio:
    Sperimentazione farmaco
  • Gruppo nosologico:
    Malattie del sistema nervoso centrale e periferico
  • Reclutamento aperto

ADVANCE CIDP-3 - Long-Term Tolerability and Safety of Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase (HYQVIA/HyQvia) for the Treatment of Chronic Inflammatory Demyelinating Polyraduculoneuropathy (CIDP).

  • Tipo studio:
    Sperimentazione farmaco
  • Gruppo nosologico:
    Malattie del sistema nervoso centrale e periferico